349 related articles for article (PubMed ID: 22583607)
1. Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors.
Diot Q; Kavanagh B; Schefter T; Gaspar L; Stuhr K; Miften M
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1024-30. PubMed ID: 22583607
[TBL] [Abstract][Full Text] [Related]
2. Lung density changes after stereotactic radiotherapy: a quantitative analysis in 50 patients.
Palma DA; van Sörnsen de Koste J; Verbakel WF; Vincent A; Senan S
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):974-8. PubMed ID: 20932655
[TBL] [Abstract][Full Text] [Related]
3. Spatial and dose-response analysis of fibrotic lung changes after stereotactic body radiation therapy.
Vinogradskiy Y; Diot Q; Kavanagh B; Schefter T; Gaspar L; Miften M
Med Phys; 2013 Aug; 40(8):081712. PubMed ID: 23927309
[TBL] [Abstract][Full Text] [Related]
4. Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Guckenberger M; Klement RJ; Kestin LL; Hope AJ; Belderbos J; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Xiao Y; Grills IS
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1074-81. PubMed ID: 23154077
[TBL] [Abstract][Full Text] [Related]
5. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
[TBL] [Abstract][Full Text] [Related]
6. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.
Pettersson N; Nyman J; Johansson KA
Radiother Oncol; 2009 Jun; 91(3):360-8. PubMed ID: 19410314
[TBL] [Abstract][Full Text] [Related]
7. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204
[TBL] [Abstract][Full Text] [Related]
8. Normal liver tissue density dose response in patients treated with stereotactic body radiation therapy for liver metastases.
Howells CC; Stinauer MA; Diot Q; Westerly DC; Schefter TE; Kavanagh BD; Miften M
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e441-6. PubMed ID: 22682809
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy for central lung tumors.
Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Clinical and Dosimetric Parameters With Radiographic Lung Injury Following Stereotactic Body Radiotherapy.
Kishan AU; Wang PC; Sheng K; Yu V; Ruan D; Cao M; Tenn S; Low DA; Lee P
Technol Cancer Res Treat; 2015 Aug; 14(4):411-8. PubMed ID: 25261069
[TBL] [Abstract][Full Text] [Related]
11. Forcing lateral electron disequilibrium to spare lung tissue: a novel technique for stereotactic body radiation therapy of lung cancer.
Disher B; Hajdok G; Gaede S; Mulligan M; Battista JJ
Phys Med Biol; 2013 Oct; 58(19):6641-62. PubMed ID: 24018569
[TBL] [Abstract][Full Text] [Related]
12. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
[TBL] [Abstract][Full Text] [Related]
15. Dose impact in radiographic lung injury following lung SBRT: Statistical analysis and geometric interpretation.
Yu V; Kishan AU; Cao M; Low D; Lee P; Ruan D
Med Phys; 2014 Mar; 41(3):031701. PubMed ID: 24593705
[TBL] [Abstract][Full Text] [Related]
16. Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions.
Lindberg K; Grozman V; Lindberg S; Onjukka E; Lax I; Lewensohn R; Wersäll P
Acta Oncol; 2019 Aug; 58(8):1178-1186. PubMed ID: 31066326
[No Abstract] [Full Text] [Related]
17. Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT).
Stephans KL; Djemil T; Tendulkar RD; Robinson CG; Reddy CA; Videtic GM
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):974-80. PubMed ID: 21300453
[TBL] [Abstract][Full Text] [Related]
18. Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system.
Eriguchi T; Takeda A; Sanuki N; Oku Y; Aoki Y; Shigematsu N; Kunieda E
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1006-11. PubMed ID: 23102838
[TBL] [Abstract][Full Text] [Related]
19. Toxicity after central versus peripheral lung stereotactic body radiation therapy: a propensity score matched-pair analysis.
Mangona VS; Aneese AM; Marina O; Hymas RV; Ionascu D; Robertson JM; Gallardo LJ; Grills IS
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):124-32. PubMed ID: 25442337
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm.
Takeda A; Sanuki N; Kunieda E; Ohashi T; Oku Y; Takeda T; Shigematsu N; Kubo A
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):442-8. PubMed ID: 18990507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
